The loss of Ionis Pharmaceuticals under GAAP for 9 months of 2020 amounted to $145 million, compared to profit $99 million in the previous year. Revenue decreased by 30.2% to $439 million compared to $629 million a year earlier.
The loss of Ionis Pharmaceuticals under GAAP for 9 months of 2020 amounted to $145 million, compared to profit $99 million in the previous year. Revenue decreased by 30.2% to $439 million compared to $629 million a year earlier. 
ir.ionispharma.com
English (US) 